Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm Morrissey

Showing results (31-40 of 172) with videos related to

Pageof 18
Sort By:
Molecular Cancer Research : MCR|June 23, 2025
A novel bispecific integrin α5β1/αv antibody reprograms the Myc-regulated basal phenotype of prostate cancer with natural killer cell-mediated tumor eliminationRaghav Joshi, Ming Zhou, Jeffrey H Lin, et al.
Cancer|May 17, 2006
Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell linesAnn Maria McCrohan, Colm Morrissey, Conor O'Keane, et al.
BJU International|July 10, 2007
Alterations in the expression of inhibitors of apoptosis during differentiation of prostate epithelial cellsRonan M Long, Colm Morrissey, Sinead Walsh, et al.
European Urology|June 27, 2016
Expression of STAT3 in Prostate Cancer MetastasesNicholas Don-Doncow, Felicia Marginean, Ilsa Coleman, et al.
Nature Communications|September 8, 2021
Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progressionSakshi Goel, Vipul Bhatia, Sushmita Kundu, et al.
Molecular Cancer Research : MCR|May 16, 2018
Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate CancerLipsa Das, Jaime M C Gard, Rytis Prekeris, et al.
Bone|May 9, 2015
Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironmentRebecca S Arnold, Stacey A Fedewa, Michael Goodman, et al.
Plos One|January 20, 2021
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculatureMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Cancers|December 2, 2020
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate CancerR William Watson, Haleema Azam, Claudia Aura, et al.
The Prostate|June 29, 2010
Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viabilityColm Morrissey, Alex Dowell, Theodore D Koreckij, et al.
Pageof 18

Showing results (31-40 of 172) with videos related to

Sort By:
Pageof 18
Molecular Cancer Research : MCR|June 23, 2025
A novel bispecific integrin α5β1/αv antibody reprograms the Myc-regulated basal phenotype of prostate cancer with natural killer cell-mediated tumor eliminationRaghav Joshi, Ming Zhou, Jeffrey H Lin, et al.
Cancer|May 17, 2006
Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell linesAnn Maria McCrohan, Colm Morrissey, Conor O'Keane, et al.
BJU International|July 10, 2007
Alterations in the expression of inhibitors of apoptosis during differentiation of prostate epithelial cellsRonan M Long, Colm Morrissey, Sinead Walsh, et al.
European Urology|June 27, 2016
Expression of STAT3 in Prostate Cancer MetastasesNicholas Don-Doncow, Felicia Marginean, Ilsa Coleman, et al.
Nature Communications|September 8, 2021
Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progressionSakshi Goel, Vipul Bhatia, Sushmita Kundu, et al.
Molecular Cancer Research : MCR|May 16, 2018
Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate CancerLipsa Das, Jaime M C Gard, Rytis Prekeris, et al.
Bone|May 9, 2015
Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironmentRebecca S Arnold, Stacey A Fedewa, Michael Goodman, et al.
Plos One|January 20, 2021
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculatureMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Cancers|December 2, 2020
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate CancerR William Watson, Haleema Azam, Claudia Aura, et al.
The Prostate|June 29, 2010
Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viabilityColm Morrissey, Alex Dowell, Theodore D Koreckij, et al.
Pageof 18